http://www.abc.net.au/news/2016-03-...-falls-after-reports-of-new-china-tax/7283022
Bellamy's has been making the most of China's growing demand for Australian-made baby formula but on Tuesday, shares were posting the second biggest losses on the ASX 200 index - down by around 6 per cent.
The company's CEO and managing director, Laura McBain, was unavailable for an interview but in a statement cited a loyal customer base.
"Bellamy's products continue to be in high demand in China, and we do not anticipate the tax will have a negative impact on sales," she said.
"Our focus continues to be on meeting demand and producing the highest quality organic products; giving mothers piece of mind that they are providing their babies a pure start to life."
Mr Colbeck said it was hard to know whether Australian products and companies like Bellamy's would be hurt by the tax.
"Talking at an Australian-Chinese business dialogue at a pretty high level I didn't see any indication of a lessening of demand for Australia's high-quality safe food products, I only saw indications that demand for those is going to continue," he said.
The Federal Government is seeking clarity about the tax from its Beijing embassy.
- Forums
- ASX - By Stock
- BAL
- China's new 17% tax on imports
China's new 17% tax on imports, page-6
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online